Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection

Arch Cardiovasc Dis. 2020 May;113(5):293-296. doi: 10.1016/j.acvd.2020.04.003. Epub 2020 Apr 24.
No abstract available

Keywords: COVID-19; Covid-19; ECG; Hydroxychloroquine; Long QT; QT long médicamenteux; QT prolonging drugs; SARS-CoV-2; Torsades de pointe.

MeSH terms

  • Algorithms
  • Antiviral Agents / adverse effects*
  • Arrhythmias, Cardiac / chemically induced*
  • Arrhythmias, Cardiac / diagnosis
  • Arrhythmias, Cardiac / etiology
  • Betacoronavirus
  • COVID-19
  • Cardiovascular Agents / adverse effects*
  • Coronavirus Infections / complications
  • Coronavirus Infections / drug therapy*
  • Electrocardiography*
  • Heart Diseases / diagnosis
  • Heart Diseases / etiology
  • Heart Diseases / virology
  • Humans
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / drug therapy*
  • Risk Factors
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • Cardiovascular Agents